[Sentinel node localization in breast cancer. Periareolar injection of radiocolloid]. / Localización del ganglio centinela en cáncer de mama. Inyección periareolar del radiocoloide.

Traditional lymphadenectomy is being replaced by sentinel node biopsy in initial management of early stage breast cancer. The aim of this study was to validate the technique in our center, where we perform preoperative lymphoscintigraphy and intraoperative detection of sentinel node, after periareolar radiotracer and peritumoral blue dye injection. Sixty patients, breast cancer stages I and II, were included. Lymphatic mapping was performed the day before surgery, after the administration of 74 MBq 99mTc sulfur colloid in periareolar subdermal tissue. Surgical detection of sentinel node through gamma probe was followed by intraoperative and occasionally delayed biopsies. Finally, full axillary node dissection was completed. Lymphoscintigraphy identified sentinel node in 78% of the patients (47/60): 43 in axilla, 4 in internal mammary chain. Probe guided axillary detection was achieved in 88% (53/60): in every patient with axillar migration in scan, in 9/13 without imaged drainage and in 1/4 with internal mammary chain migration. Sensitivity of blue dye technique was 75% (45/60), the concordance between both procedures being high. Considering both, the overall success rate of surgical detection was 90% (54/60); if we exclude those patients who showed exclusive extraaxillar drainage, the success rate reaches 95%. Malignancy was found in 24% of sentinel nodes removed (13/54); it being the only metastatic axillary node in 4/13. No false negative sentinel nodes were found. Therefore, negative predictive value and accuracy were 100%. These results allow us to validate the technique in our center.

[Sentinel node biopsy in patients with multifocal and multicentric breast cancer: A 5-year follow-up]. / Biopsia de ganglio centinela en pacientes con cáncer de mama multifocal y multicéntrico: 5 años de seguimiento.

OBJECTIVE: Sentinel lymph node biopsy (SLNB) as a staging procedure in multiple breast cancer is a controversial issue. We have aimed to evaluate the efficacy of sentinel node (SN) detection in patients with multifocal or multicentric breast cancer as well as the safety of its clinical application after a long follow-up. MATERIAL AND METHODS: A prospective descriptive study was performed. Eighty-nine patients diagnosed of multiple breast cancer (73 multifocal; 16 multicentric) underwent SLNB. These patients were compared to those with unifocal neoplasia. Periareolar radiocolloid administration was performed in most of the patients. Evaluation was made at an average of 67.2 months of follow-up (32-126 months). RESULTS: Scintigraphic and surgical SN localization in patients with multiple breast cancer were 95.5% and 92.1%, respectively. A higher percentage of extra-axillary nodes was observed than in the unifocal group (11.7% vs 5.4%) as well as a significantly higher number of SN per patient (1.70 vs 1.38). The rate of SN localization in multicentric cancer was slightly lower than in multifocal cancer (87.5% vs 93.1%), and the finding of extra-axillary drainages was higher (20% vs 10%). Number of SN per patient was significantly higher in multicentric breast cancer (2.33 vs 1.57). No axillary relapses have been demonstrated in the follow-up in multiple breast cancer patients group. CONCLUSIONS: SLNB performed by periareolar injection is a reliable and accurate staging procedure of patients with multiple breast cancer, including those with multicentric processes.

[The utility of gammagraphy with Tc 99-labelled dimercaptosuccinic acid (DMSA) in the protocol for studying urinary infection in a 2nd-level hospital]. / Utilidad de la gammagrafía con ácido dimercaptosuccínico (DMSA) marcado con Tc99 en el protocolo de estudio de la infección urinaria en un hospital de segundo nivel.

OBJECTIVE: Not all hospitals in our country have their own nuclear medicine laboratory. Most small and medium size hospitals must arrange their radioisotope studies with private clinics. The objective of this study was to assess if a single DMSA scan performed after an acute infection in a group of patients chosen according to certain risk criteria would allow the selection of those who run the risk of progressive renal damage. PATIENTS AND METHODS: A descriptive and retrospective study of the clinical records of 65 patients under 14 years of age with urinary tract infection (UTI) seen at our institution between 1994 and 1995 and on whom a DMSA scan had been performed was carried out. The study groups was formed by the fifteen children with scintigraphic findings compatible with renal scarring. The fifty children with normal DMSA scans were used as controls. RESULTS: Renal scarring was found more often in patients over one year of age (p < 0.05), in those with reinfections (p < 0.001) and in those kidneys with grade III vesicoureteral reflux (VUR, p < 0.05). The most severe lesions, with reduction of renal size, shape abnormalities and diminished uptake of the tracer were found together with VUR. The renal sonogram performed during the acute stage of the UTI was able to detect only four of the six children most severely affected. CONCLUSIONS: Delaying the practice of the DMSA scan until 6 months after the last episode of bacteriuria would allow selection of those patients at the highest risk of progressive renal damage. This guideline would reduce scintigraphic studies 30 to 90%, since it would avoid repeated studies in those children with abnormal findings in the acute stage. The practice of the radioisotope study only in a reduced subset of patients selected on the basis of risk criteria such as recurrent UTI, VUR or suspected pyelonephritis does not allow detection of all scars.